NCT06705855 A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury
| NCT ID | NCT06705855 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | NIRS |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-29 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-05-29 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Acute kidney injury (AKI) is a complication of cardiac surgery that can affect outcome. Near Infrared Spectroscopy (NIRS) is a technology that uses light to determine how well oxygenated tissues are. This technology is routinely used in cardiac surgery to measure the oxygen level in the brain by placing a sensor sticker on the forehead. The purpose of the study is to determine whether NIRS sensor stickers placed on the skin over the kidney can predict AKI better than when sensors are placed on the skin over the participant's limbs. This study is being conducted by investigators from the department of anesthesiology at the University of Utah.
Eligibility Criteria
Inclusion Criteria: * We will enroll a convenience sample of adult cardiac surgery patients undergoing procedures that require cardiopulmonary bypass (CPB) and who are at risk for AKI. Exclusion Criteria: * Exclusion criteria will include less than age 18 years old, preoperative end-stage kidney disease requiring dialysis, emergency surgery, or patient refusal.
Contact & Investigator
Natalie Silverton, MD
PRINCIPAL INVESTIGATOR
University of Utah
Frequently Asked Questions
Who can join the NCT06705855 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying NIRS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06705855 currently recruiting?
Yes, NCT06705855 is actively recruiting participants. Contact the research team at natalie.silverton@hsc.utah.edu for enrollment information.
Where is the NCT06705855 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT06705855 clinical trial?
NCT06705855 is sponsored by University of Utah. The principal investigator is Natalie Silverton, MD at University of Utah. The trial plans to enroll 100 participants.